HUMACYTE INC
HUMA·44486Q103·US·Common Stock·Healthcare - Biotechnology-Activist
HUMA (HUMACYTE INC) is held by 83 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($7.9M), Alyeska Investment Group, L.P. ($4.7M), BlackRock, Inc. ($3.8M). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 48 funds bought HUMA.
83
Holders
(8 Elite)
$37.2M
Total Value
51% (94)
Consensus
48 buying - 46 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 12, 2026 · Insiders Sep 15, 2026 · Activists Jul 28, 2026 · Congress Aug 5, 2026
InsiderJAJones Keith AnthonyBuy $6KSep 14, 2026
InsiderJAJones Keith AnthonyBuy $7KAug 20, 2026
InsiderJAJones Keith AnthonyBuy $18KAug 17, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 102
1 / 6
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer